Journal of Hypertension
The Journal of Hypertension is the Official Journal of the European Society of Hypertension and International Society of Hypertension. The journal consistently attracts the most important and highly innovative papers from the current research; our commitment to rapid publication ensures that these are published in the fastest time possible. In addition to primary papers from world-renowned experts, the Journal contains authoritative reviews that summarize and evaluate the most significant recent developments. Also included are special reports, original short papers containing innovative and time-sensitive information.
New Editor-in-Chief, New Impact Factor
Giuseppe Mancia, has been appointed Editor in Chief of the Journal of Hypertension for a period of three years. The Journal of Hypertension is the official journal of the European Society of Hypertension and International Society of Hypertension with a slightly increased new Impact Factor of 4.092.
Prof. Mancia, who has served for many years on the journal’s Editorial Board, succeeds Alberto Zanchetti with whom he collaborated closely. Alberto Zanchetti was Editor-in-Chief of Journal of Hypertension from 1995 until his death in March this year. He invested enormous time and effort in the Journal, encouraging its growth and quality and his contribution was instrumental to its success.
Giuseppe Mancia is Professor Emeritus at the University Milano-Bicocca. He has been Chairman of the Scientific and Organizing Committee of European Society of Hypertension meetings, and past President of European Society of Hypertension, International Society of Hypertension, European Society of Clinical Investigation and Italian Society of Hypertension. Prof. Mancia has chaired the Task Force of the ESH/ESC Hypertension Guidelines in 2003, 2007, 2013 and the upcoming new 2018 Guidelines.
Prof. Mancia has published more than 2400 original papers in peer-reviewed Journals and has edited or authored more than 20 books on hypertension, cardiovascular and metabolic diseases. Prof. Mancia is listed among the “highly cited” researchers of ISI (Philadelphia). His publications have received 177.000 citations with a H-index of 159.
Congratulations to the new Editor and we look forward to the continuing success and development of the Journal under his editorship.
For the latest advances in hypertension research, turn to Blood Pressure, a primary source for authoritative and timely information on all aspects of hypertension research and management. Features include:
- Physiology and pathophysiology of blood pressure regulation
- Primary and secondary hypertension
- Cerebrovascular and cardiovascular complications
- Detection, treatment and follow-up of hypertension
- Non-pharmacological and pharmacological management
- Large outcome trials in hypertension
Special features include the Personal View section, in which distinguished scientists present their thoughts on hypertension, Viewpoints, Debates, and Reviews that address important topics of great current interest. A special meetings calendar, the Blood Pressure Diary, as well as a section in which Hypertension Societies world-wide present their activities are also provided. Articles requiring extensive space, such as monographs, doctoral theses and congress transactions, are published as supplements.
The following is a list of medical journals which frequently cover information with relevance to hypertension research and treatment.
- American Journal of Cardiology
- American Journal of Hypertension
- Art, Thro, Vasc Bio
- British Medical Journal
- Circulation Research
- Diabetes Care
- European Heart Journal
- High Blood Pressure and Cardiovascular Prevention
- Journal of the American College of Cardiology
- Journal of the American Society of Nephrology
- Kidney International
- New England Journal of Medicine